Profil
Gary M.
Gordon is currently the President at Kowa Research Institute, Inc. He previously worked as the Principal at Genelabs Technologies, Inc. and as the Chief Financial Officer & VP-Business Development at BioStratum, Inc. Dr. Gordon holds an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Cornell University.
Postes actifs de Gary M. Gordon
| Sociétés | Poste | Début |
|---|---|---|
Kowa Research Institute, Inc.
Kowa Research Institute, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | President | 01/01/2012 |
Anciens postes connus de Gary M. Gordon
| Sociétés | Poste | Fin |
|---|---|---|
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Directeur Financier/CFO | 05/07/2011 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Corporate Officer/Principal | - |
Formation de Gary M. Gordon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kowa Research Institute, Inc.
Kowa Research Institute, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
















